HB1424
(Title) (New Title) allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.
BodyDocket Description
H Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 21
H Public Hearing: 01/29/2020 11:00 am LOB 205
H Subcommittee Work Session: 02/12/2020 10:00 am LOB 104
H==RECESSED== Executive Session: 02/13/2020 11:00 am LOB 205
H==CONTINUED== Executive Session: 02/18/2020 01:00 pm LOB 205 (if not exec'd on the 13th)
H Subcommittee Work Session: 02/18/2020 10:00 am LOB 209 (if not exec'd on the 13th)
H Committee Report: Ought to Pass with Amendment # 2020-0630h (NT) for 03/11/2020 (Vote 19-1; CC) HC 10 P. 19
HAmendment # 2020-0630h (NT): AA VV 03/11/2020 HJ 7 P. 33
HOught to Pass with Amendment 2020-0630h (NT): MA VV 03/11/2020 HJ 7 P. 33
SIntroduced 06/16/2020, and Laid on Table, MA, VV; 06/16/2020; SJ 8